IGC Pharma
IGC
#10656
Rank
A$41.42 M
Marketcap
A$0.40
Share price
-1.75%
Change (1 day)
-36.11%
Change (1 year)
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -A$9.75 Million

According to IGC Pharma's latest financial reports the company's current earnings are A$1.18 Million. In 2025 the company made an earning of -A$7.62 Million, an increase over its 2024 earnings that were of -A$12.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.75 Million27.88%
2025 -A$7.62 Million-39.35%
2024 -A$12.56 Million-37.72%
2023 -A$20.17 Million1.19%
2022 -A$19.93 Million21.96%
2021 -A$16.34 Million27.13%
2020 -A$12.86 Million57.16%
2019 -A$8.18 Million85.47%
2018 -A$4.41 Million52.76%
2017 -A$2.89 Million-16.23%
2016 -A$3.45 Million-28.75%
2015 -A$4.84 Million-19.59%
2014 -A$6.02 Million6.79%
2013 -A$5.64 Million-9.47%
2012 -A$6.23 Million-74.03%
2011 -A$23.96 Million119.78%
2010 -A$10.9 Million62.02%
2009 -A$6.73 Million74.39%
2008 -A$3.86 Million-313.12%
2007 A$1.81 M-35.94%
2006 A$2.82 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
A$0.69 B-7,556.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$0.92 B-9,990.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
A$0.39 B-4,382.25%๐Ÿ‡บ๐Ÿ‡ธ USA